U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}
structurally diverse
Status:
Investigational
Source:
INN:pemlimogene merolisbac [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
INN:axalimogene filolisbac [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT00327652: Phase 1 Interventional Completed Neoplasm Metastasis
(2006)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03006302: Phase 2 Interventional Active, not recruiting Metastatic Pancreatic Adenocarcinoma
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Designated
Source:
FDA ORPHAN DRUG:386212
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Other

Class:
STRUCTURALLY DIVERSE